Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
LigoCyte, established in 1998, has committed its expertise in immunology to the discovery and development of therapeutic drugs and vaccines for the prevention of inflammatory and infectious diseases. The company’s immunomodulatory drug discovery activities support its pipeline of therapeutic candidates. LigoCyte’s world-class scientists and leading-edge technologies are focused on the clinical development of lead candidates to establish strategic relationships within the pharmaceutical industry. In 2003, LigoCyte formed a research collaboration for an anti-inflammatory monoclonal antibody with Abbott Laboratories. The company’s ProteoFlow® high content assay technology streamlines the drug development process by testing inhibitors in a fully human, physiologic flow environment. ( www.ligocyte.com )
LigoCyte Pharmaceuticals , Inc.
920 Technology Blvd.
Bozeman, Montana 59718-4001
USA
Tel: (406) 585-2733
Fax: (406) 585-2766